AzarGen Biotechnologies

About:

AzarGen is a biotechnology company focused on developing human therapeutic proteins using advanced genetic engineering & synthetic biology.

Website: http://www.azargen.com/

Description:

AzarGen is a biotechnology company utilising advanced genetic engineering and synthetic biology techniques to express biopharmaceutical compounds of high value.Our focus is to use plants as bioreactors to develop a pipeline of novel and patentable compounds with special emphasis on complex therapeutic proteins. AzarGen is proving the viability of its plant-based expression platform through a lead candidate, being a recombinant human therapeutic protein. AzarGen’s product is expected to increase the survivability of premature-born infants in the developed and developing world with higher clinical efficiency and at lower cost.

Total Funding Amount:

$3.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Stellenbosch, NA - South Africa, South Africa

Founded Date:

2009-01-01

Contact Email:

cobus(AT)azargen.com

Founders:

Cobus Zwiegelaar, Mauritz Venter

Number of Employees:

1-10

Last Funding Date:

2016-01-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai